BioHealth News Archive

Tech Council of Maryland Awarded Three-Year Cyber Workforce Training Grant

Tech Council of Maryland Awarded Three-Year Cyber Workforce Training Grant

The Tech Council of Maryland (TCM), Maryland’s largest technology trade association for life science and technology, has been awarded a three-year, $225,000 federal grant…

Read More
Sucampo Announces Extension of AMITIZA License and Collaboration Agreement With Takeda

Sucampo Announces Extension of AMITIZA License and Collaboration Agreement With Takeda

Sucampo Pharmaceuticals has announced that it signed an amendment to the existing collaboration and license agreement (Collaboration Agreement) covering the United States and Canada…

Read More
First look at the $200M Maryland Proton Treatment Center in Baltimore – Baltimore Business Journal

First look at the $200M Maryland Proton Treatment Center in Baltimore – Baltimore Business Journal

University of Maryland, Baltimore’s $200 million proton therapy center will begin treating cancer patients in a year. The center’s first of five treatment rooms…

Read More
2014 Eastern Shore Business Competition

2014 Eastern Shore Business Competition

The Eastern Shore Entrepreneurship Center (ESEC), Rural Maryland Council (RMC), and Maryland Capital Entreprises (MCE) have joined together to offer the third annual Eastern Shore Business Competition.…

Read More
CASIS Announces Grant Awards for Enabling Technologies – CASIS – Center for the Advancement of Science in Space

CASIS Announces Grant Awards for Enabling Technologies – CASIS – Center for the Advancement of Science in Space

The Center for the Advancement of Science in Space (CASIS) has announced grant awards for three projects focused on enabling technologies from the International…

Read More
DreamIt Health Baltimore Now Accepting Applications for 2015

DreamIt Health Baltimore Now Accepting Applications for 2015

The global accelerator DreamIt Ventures has announced that it is now accepting applications for DreamIt Health Baltimore, a four-month acceleration program based in one the…

Read More
Biotech’s Builder: How The Pharma’s Landlord Could Benefit From The Drug Boom

Biotech’s Builder: How The Pharma’s Landlord Could Benefit From The Drug Boom

As the tech industry falls back in love with urban America, Joel Marcus, landlord to the booming biotechnology business, is perfectly positioned to strike…

Read More
Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners

Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners

QIAGEN N.V. (NASDAQ: QGEN)(Frankfurt Prime Standard: QIA) announced today that its business area, QIAGEN Bioinformatics, has been named by Genomics England (GeL) an assessment…

Read More
Thanks to resistance, drug companies retiring antibiotic after antibiotic

Thanks to resistance, drug companies retiring antibiotic after antibiotic

Antibiotic resistance is taking its toll on the pharmaceutical industry: Drugs are getting retired from clinical circulation, because many are starting to get rendered…

Read More
UCSF-Developed Entrepreneurship Course for Life Scientists Launched by NIH – ucsf.edu

UCSF-Developed Entrepreneurship Course for Life Scientists Launched by NIH – ucsf.edu

The National Institutes of Health (NIH) has launched a pilot program to help life science entrepreneurs commercialize their technology, based on a course developed…

Read More
Sitting in Chairs Most of the Day Can Kill You, But a Little Standing Can Bring Back Your Health – Scientific American

Sitting in Chairs Most of the Day Can Kill You, But a Little Standing Can Bring Back Your Health – Scientific American

Chairs: we sit in them, work in them, shop in them, eat in them and date in them. Americans sit for most of their…

Read More
Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)

Synthetic Biologics Receives Orphan Drug Designation for SYN-005 Treatment for Whooping Cough (Pertussis)

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and…

Read More
GSK plans acquisition of Novartis OTC line – New Zealand Doctor

GSK plans acquisition of Novartis OTC line – New Zealand Doctor

Pharmaceutical giant GlaxoSmithKline (GSK) is planning to acquire the over-the-counter arm of global healthcare group Novartis. The Commerce Commission is currently considering GSK’s application,…

Read More
Technology Trends To Watch: 2015 – CEA

Technology Trends To Watch: 2015 – CEA

Ideas are the juice that powers our economy with innovation happening fast on multiple technology fronts. Rapid developments are in play in areas as…

Read More
Steve Case: Great Companies Will Thrive, Despite Where They’re Based

Steve Case: Great Companies Will Thrive, Despite Where They’re Based

On a massive bus in the heart of America, a group of tech entrepreneurs and investors are spreading glad tidings about entrepreneurship and startups…

Read More